Cardiovascular Information System Market Analysis, Size And Growth 2025 To 2034


Created for forward-thinking professionals, this report equips teams with the insights needed to compete effectively in the cardiovascular information system space.

How Fast Is The Cardiovascular Information System Market Growing Towards 2025?
The cardiovascular information system market size has grown strongly in recent years. It will grow from $1.16 billion in 2024 to $1.26 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to electronic health records (EHR) integration, need for workflow optimization, patient engagement and empowerment, cardiovascular disease burden and interoperability and data exchange.

The cardiovascular information system market size is expected to see strong growth in the next few years. It will grow to $1.76 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to value-based care initiatives, artificial intelligence and machine learning, cybersecurity and data privacy, and remote cardiac rehabilitation programs. Major trends in the forecast period include cloud-based solutions, advanced analytics and reporting, telemedicine integration, artificial intelligence and automation and cybersecurity measures.

Get your free sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15751&type=smp

Cardiovascular Information System Market Drivers And Opportunities
The increasing number of cardiovascular disease patients is expected to propel the growth of the cardiovascular information system market going forward. Cardiovascular disease (CVD) refers to a group of conditions that involve narrowed or blocked blood vessels, which can lead to various complications such as heart attacks, chest pain (angina), or strokes. Cardiovascular disease, encompassing a range of heart and blood vessel issues, has become a prevalent health concern globally. The leading cause of the increase is the presence of risk factors such as high blood pressure, high cholesterol levels, smoking, obesity, diabetes, and a sedentary lifestyle. Cardiovascular information systems (CVIS) efficiently manage patient data, enhance communication among healthcare professionals, and support quicker and more informed decision-making in diagnosis and treatment. For instance, in May 2024, according to the Singapore Heart Foundation (SHF), a Singapore-based non-profit organization, ischemic heart diseases resulted in 5,302 deaths, showing a slight increase from 5,290 deaths in 2022. Therefore, the increasing number of cardiovascular disease patients is driving the growth of the cardiovascular information system market.

How Is The Cardiovascular Information System Market Segmented?
The cardiovascular information systemmarket covered in this report is segmented –

1) By Components: Hardware, Software, Services
2) By Mode Of Operation: Web-Based, Cloud-Based, On-Site
3) By Application: Catheterization, Echocardiography, Electrocardiogram, Electrophysiology, Other Applications
4) By End User: Hospitals, Clinics, Cardiac Cath Labs, Ambulatory Surgical Centers, Diagnostic Centers

Subsegments:
1) By Hardware: Servers, Storage Devices, Network Equipment, Workstations
2) By Software: Cardiovascular Imaging Software, Electronic Health Record (EHR) Software, Cardiology Information System (CIS) Software, Data Management Software
3) By Services: Installation And Integration Services, Support And Maintenance Services, Training And Consulting Services

What Are The Key Trends Shaping The Cardiovascular Information System Industry?
Major companies operating in the cardiovascular information system market are focusing on developing next-generation insertable monitors to improve patient outcomes and streamline clinical workflows. Next-generation cardiac insertable monitors represent a significant advancement in cardiac care, offering improved diagnostic capabilities, enhanced patient comfort, and better overall management of cardiovascular conditions. For instance, in October 2023, Boston Scientific Corporation launched the LUX-Dx II+ Insertable Cardiac Monitor (ICM) System, a next-generation insertable monitor for long-term monitoring of arrhythmias associated with conditions such as atrial fibrillation (AF), cryptogenic stroke, and syncope. It offers dual-stage algorithms for accurate arrhythmia detection, remote programming capabilities for adjustments without clinic visits, and a downloadable app for convenient remote monitoring, enhancing clinical decision-making and patient care.

Major Companies Operating In The Cardiovascular Information System Market Are:
Major companies operating in the cardiovascular information system market are McKesson Corporation, IBM Corporation, Medtronic Plc., Siemens AG, Fujifilm Holding Corporation, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Boston Scientific Corporation, Cerner Corporation, Epic Systems Corporation, Carestream Health Inc., Allscripts Healthcare LLC, NextGen Healthcare LLC, Esaote S.p.A., Intelerad Medical Systems Incorporated, Merge Healthcare, Canon Medical Systems Corporation, CareCloud Corp., LivaNova Plc., Lumedx Corporation, Digisonics Inc., Medigy LLC, INFINITT Healthcare Co Ltd., CREALIFE Medical Technology Inc., Epic Systems Corporation

View the full cardiovascular information system market report here:
https://www.thebusinessresearchcompany.com/report/cardiovascular-information-system-global-market-report

Regional Analysis: Opportunities And Challenges In The Cardiovascular Information System Market
North America was the largest region in the cardiovascular information system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiovascular information system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Scope, Share Analysis And Growth 2025

Image
Focused on real-world business use, this report highlights what’s changing in the hypertrophic cardiomyopathy (hcm) therapeutics market and what companies should prepare for next. What Is The Projected Market Size & Growth Rate Of The Hypertrophic Cardiomyopathy (HCM) Therapeutics Market? The hypertrophic cardiomyopathy (hcm) therapeutics market size has grown marginally in recent years. It will grow from $1.34 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 1.5%. The growth in the historic period can be attributed to diagnostic advancements, increased disease awareness, drug development and approvals, rising healthcare expenditure, government initiatives and funding. The hypertrophic cardiomyopathy (hcm) therapeutics market size is expected to see steady growth in the next few years. It will grow to $1.56 billion in 2029 at a compound annual growth rate (CAGR) of 3.4%. The growth in the forecast period can be attributed to genetic research and ...
Read more

Glycomics or Glycobiology Market Scope, Share Analysis And Growth 2025

Image
Backed by rigorous analysis and deep industry knowledge, this study is designed to support growth and investment decisions in the glycomics or glycobiology market. How Big Is The Glycomics or Glycobiology Market In 2025? The glycomics or glycobiology market size has grown rapidly in recent years. It will grow from $1.85 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to increased awareness of glycans in biological systems, expansion of glycan-related database and resources, rise in collaborative research initiatives, advancements in glycan synthesis and engineering, glycan biomarker identification. The glycomics or glycobiology market size is expected to see rapid growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to glycan-focused artificial intelligence (AI) and data analy...
Read more

Smart Crop Monitoring Market Overview, Analysis And Demand By 2034

Image
Aimed at strategic decision-makers, this report explores current opportunities, emerging trends, and market dynamics shaping the smart crop monitoring sector. How Big Is The Smart Crop Monitoring Market In 2025? The smart crop monitoring market size has grown rapidly in recent years. It will grow from $3.47 billion in 2024 to $4.09 billion in 2025 at a compound annual growth rate (CAGR) of 18.0%. The growth in the historic period can be attributed to rising demand for high crop production, increasing global population, significant growth in IOT technology, rising need for sustainable agricultural practices, and increasing regulatory pressures. The smart crop monitoring market size is expected to see rapid growth in the next few years. It will grow to $7.83 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to the development of automated irrigation systems, the growing trend of farm-to-table movements, an increase in ag...
Read more